Cell Journal

Scope & Guideline

Unlocking the Secrets of Life at the Cellular Level

Introduction

Welcome to your portal for understanding Cell Journal, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2228-5806
PublisherROYAN INST
Support Open AccessNo
CountryIran
TypeJournal
Convergefrom 2011 to 2024
AbbreviationCELL J / Cell J.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 19395-4644, TEHRAN 00000, IRAN

Aims and Scopes

The Cell Journal focuses on advancing knowledge in cell biology, regenerative medicine, and therapeutic applications, emphasizing innovative research methodologies and emerging technologies.
  1. Cell Biology and Regenerative Medicine:
    Research in this area explores the mechanisms of cell function, differentiation, and regeneration, particularly using stem cells and their applications in treating various diseases.
  2. Cancer Research:
    The journal frequently publishes studies on cancer biology, including mechanisms of tumor progression, resistance to therapy, and potential therapeutic targets.
  3. Molecular and Cellular Mechanisms:
    A significant focus is on understanding molecular pathways that regulate cell behavior, apoptosis, and responses to stressors, which are crucial for both health and disease.
  4. Bioinformatics and Computational Biology:
    The integration of bioinformatics in analyzing genetic and molecular data is a key aspect, allowing for the identification of potential biomarkers and therapeutic targets.
  5. Clinical Applications and Trials:
    The journal also emphasizes clinical studies that assess the safety and efficacy of novel therapeutic strategies, including stem cell therapies and regenerative approaches.
Recent publications in the Cell Journal highlight several emerging themes that reflect current trends in biomedical research and the evolving landscape of cell and molecular biology.
  1. Organoids and 3D Cell Cultures:
    The use of organoids and three-dimensional cell culture systems is gaining traction, allowing for more physiologically relevant models for studying disease mechanisms and drug responses.
  2. Nanotechnology in Medicine:
    There is a notable increase in research focused on nanomaterials for drug delivery and imaging, showcasing their potential in enhancing therapeutic efficacy and precision.
  3. Gene Editing Technologies:
    The application of CRISPR and other gene-editing technologies is trending, with studies exploring their potential in genetic disorders and cancer treatment.
  4. Immunotherapy and Cellular Therapies:
    Research on immunotherapeutic approaches, including CAR-T cell therapy and other cellular interventions, is expanding, reflecting a significant shift towards innovative cancer treatments.
  5. Microbiome and Health:
    Emerging studies are increasingly investigating the role of the microbiome in health and disease, highlighting its influence on immune response and therapeutic outcomes.

Declining or Waning

Over the years, certain research themes have seen a reduction in publication frequency within the Cell Journal, indicating a potential shift in focus among researchers.
  1. Traditional Pharmacology Studies:
    Research centered on conventional pharmacological approaches appears to be declining as interest shifts toward molecular and cellular mechanisms and personalized medicine.
  2. Animal Models in Basic Research:
    While still important, the reliance on traditional animal models is waning in favor of more sophisticated in vitro systems and human-derived models that better mimic human physiology.
  3. Basic Stem Cell Biology:
    Basic research on stem cells without a clear translational application seems to be less frequent, with a growing emphasis on clinical and therapeutic applications.
  4. Epidemiological Studies:
    There seems to be a decrease in purely observational epidemiological studies, as more integrative and translational approaches are favored for their potential clinical impact.

Similar Journals

BMC Molecular and Cell Biology

Championing high-quality insights in molecular and cell biology.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Genes & Diseases

Unlocking the secrets of genes to combat diseases.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

Inflammation and Regeneration

Uncovering the links between immune response and tissue regeneration.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

DIFFERENTIATION

Advancing the Frontiers of Cellular Understanding
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

International Journal of Molecular and Cellular Medicine

Elevating Understanding in Molecular and Cellular Medicine
Publisher: CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTERISSN: 2251-9637Frequency: 4 issues/year

International Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.

STEM CELLS AND DEVELOPMENT

Unraveling the Mysteries of Development and Regeneration
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

Stem Cells International

Unlocking the Potential of Regenerative Medicine
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Stem Cell Research & Therapy

Pioneering Research in Regenerative Therapies
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Journal of Molecular Cell Biology

Connecting the world of genetics and cellular research.
Publisher: OXFORD UNIV PRESSISSN: 1674-2788Frequency: 6 issues/year

The Journal of Molecular Cell Biology, published by Oxford University Press, is a leading platform for groundbreaking research in the fields of cell biology, genetics, and molecular biology. With an impact factor that places it in the Q1 and Q2 quartiles across key academic categories, this journal has become an essential resource for researchers and professionals committed to advancing our understanding of cellular mechanisms and genetic processes. Since becoming Open Access in 2019, it has enhanced the accessibility of high-quality research, fostering collaboration and knowledge sharing within the scientific community. The journal's Scopus rankings reflect its significant impact in the field, particularly in genetics and molecular biology, ranking within the top percentiles. With a convergence of research spanning from 2009 to 2024, the Journal of Molecular Cell Biology remains at the forefront of innovative discoveries and critical discussions, making it a vital resource for students, academics, and industry experts alike.

DNA AND CELL BIOLOGY

Connecting Researchers to the Heart of Biology
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.